1-7 of 7
Cassandra Choe-Juliak
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A phase 1b study of AFM13 in combination with pembrolizumab in patients with relapsed or refractory Hodgkin lymphoma

Clinical Trials & Observations
Nancy L. Bartlett, Alex F. Herrera, Eva Domingo-Domenech, Amitkumar Mehta, Andres Forero-Torres, Ramon Garcia-Sanz, Philippe Armand, Sumana Devata, Antonia Rodriguez Izquierdo, Izidore S. Lossos, Craig Reeder, Taimur Sher, Robert Chen, Sylvia E. Schwarz, Leila Alland, Andras Strassz, Kim Prier, Cassandra Choe-Juliak, Stephen M. Ansell
Journal: Blood
Blood (2020) 136 (21): 2401–2409.
https://doi.org/10.1182/blood.2019004701
Published: 2020
Includes: Supplemental data
Journal Articles

A Phase 1b Study Investigating the Combination of the Tetravalent Bispecific NK Cell Engager AFM13 and Pembrolizumab in Patients with Relapsed/Refractory Hodgkin Lymphoma after Brentuximab Vedotin Failure: Updated Safety and Efficacy Data

Nancy L. Bartlett, MD, Robert W. Chen, MD, Eva Domingo-Domenech, MD, Andres Forero-Torres, MD, Ramon Garcia-Sanz, MD PhD, Philippe Armand, MD PhD, Sumana Devata, MD, Antonia Rodriguez Izquierdo, MD, Izidore S. Lossos, MD, Craig B. Reeder, MD, Taimur Sher, MD, Cassandra Choe-Juliak, MD MS, Kim Prier, Sylvia Schwarz, PhD, Andras Strassz, MD, Leila Alland, MD, Stephen M. Ansell, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1620.
https://doi.org/10.1182/blood-2018-99-118506
Published: 2018
Journal Articles

A Phase 1 Study Investigating AFM11 in Patients with Relapsed/Refractory B Cell Precursor Acute Lymphoblastic Leukemia: Preliminary Results

Galina Salogub, MD PhD, Jiri Mayer, MD, Frantisek Folber, MD PhD, Sebastian Grosicki, MD PhD, Aleksander B Skotnicki, MD PhD, Anna Prochwicz, MD, Alexander Myasnikov, MD, Alexander Gural, MD, Oliver Schoenborn-Kellenberger, MSc, Charlie Brindley, PhD, Stefan Knackmuss, PhD, Sylvia Schwarz, PhD, Sandra Schmich, Cassandra Choe-Juliak, MD MS, Andras Strassz, MD, Leila Alland, MD, Michael Doubek, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3969.
https://doi.org/10.1182/blood-2018-99-118136
Published: 2018
Journal Articles

Selinexor Shows Synergy in Combination with Pomalidomide and Low Dose Dexamethasone in Patients with Relapsed / Refractory Multiple Myeloma

Christine Chen, MD, Rami Kotb, MD FRCPC., Michael Sebag, MD PhD, Richard LeBlanc, MD, Heather J. Sutherland, MD PhD, Darrell White, MD, Christopher P. Venner, MD, Tom Kouroukis, MD, Debra Bergstrom, BSc, MD FRCPC, Arleigh McCurdy, MD, Marc Lalancette, MDFRCP-C, William Bensinger, MD, Suzanne Lentzsch, MD PhD, Aldo Del Col, BSPharm, MBA, Michael Kauffman, MD PhD, Sharon Shacham, PhD MBA, Jacqueline Jeha, Carla Picklesimer, Jean-Richard Saint-Martin, Cassandra Choe-Juliak, MD, Nizar J. Bahlis, MD
Journal: Blood
Blood (2016) 128 (22): 3330.
https://doi.org/10.1182/blood.V128.22.3330.3330
Published: 2016
Journal Articles

Selinexor and Low Dose Dexamethasone (Sd) in Patients with Lenalidomide, Pomalidomide, Bortezomib, Carfilzomib and Anti-CD38 Ab Refractory Multiple Myeloma (MM): STORM Study

Dan T. Vogl, MD, David Dingli, MD PhD FRCP, R. Frank Cornell, MD MS, Carol Ann Huff, MD, Sundar Jagannath, MD, Divaya Bhutani, Rachid Baz, MD, Ajay K Nooka, MD MPH, Joshua Richter, MD, Craig E. Cole, MD, Ravi Vij, Andrzej Jakubowiak, MD, Rafat Abonour, MD, Gary J. Schiller, MD, Terri L. Parker, MD, Luciano J. Costa, MD PhD, David Kaminetzky, MD, James Hoffman, MD, Andrew J. Yee, MD, Ajai Chari, MD, David S. Siegel, MD PhD, Rafael Fonseca, MD, Scott VanWier, Gregory Ahmann, Ilsel Lopez, Michael Kauffman, MD PhD, Sharon Shacham, PhD MBA, Jean-Richard Saint-Martin, Carla Picklesimer, Sharon Friedlander, PhD, Cassandra Choe-Juliak, MD, A. Keith Stewart, MBChB
Journal: Blood
Blood (2016) 128 (22): 491.
https://doi.org/10.1182/blood.V128.22.491.491
Published: 2016
Journal Articles

A Phase 1/2 Study of the Second Generation Selective Inhibitor of Nuclear Export (SINE) Compound, KPT-8602, in Patients with Relapsed Refractory Multiple Myeloma

R. Frank Cornell, MD MS, Adriana C Rossi, MD, MSc, Rachid Baz, MD, Craig C Hofmeister, Chaim Shustik, MD, Joshua R. Richter, MD, Christine Chen, MD, Dan T. Vogl, MD, Sharon Shacham, PhD MBA, Erkan Baloglu, PhD MBA, William Senapedis, PhD, Joel Ellis, PhD, Sharon Friedlander, PhD, Cassandra Choe-Juliak, MD, Christopher L Cubitt, PhD, Joel G Turner, PhD, Daniel Sullivan, MD MS, Michael Kauffman, MD PhD
Journal: Blood
Blood (2016) 128 (22): 4509.
https://doi.org/10.1182/blood.V128.22.4509.4509
Published: 2016
Journal Articles

Selinexor in Combination with Bortezomib and Dexamethasone (SdB) Demonstrates Significant Activity in Patients with Refractory Multiple Myeloma (MM) Including Proteasome-Inhibitor Refractory Patients: Results of the Phase I Stomp Trial

Nizar J. Bahlis, MD, Rami Kotb, MD FRCPC., Michael Sebag, MD PhD, Heather J. Sutherland, MD PhD, Richard LeBlanc, MD, Darrell White, MD, Christopher P. Venner, MD, Tom Kouroukis, MD, Debra Bergstrom, BSc, MD FRCPC, Arleigh McCurdy, MD, Marc Lalancette, MD FRCPC, William Bensinger, MD, Suzanne Lentzsch, MD PhD, Aldo Del Col, BSPharm, MBA, Michael Kauffman, MD PhD, Sharon Shacham, PhD MBA, Jacqueline Jeha, Carla Picklesimer, Jean-Richard Saint-Martin, Cassandra Choe-Juliak, MD, Christine Chen, MD
Journal: Blood
Blood (2016) 128 (22): 977.
https://doi.org/10.1182/blood.V128.22.977.977
Published: 2016